Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary)

被引：4
|
作者：
Rajput, FS [1 ]
Gnanasekeram, H [1 ]
Satwani, S [1 ]
Davenport, JD [1 ]
Gracely, EJ [1 ]
Gopalan, R [1 ]
Narula, J [1 ]
机构：
[1] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 02期
关键词：
D O I：
10.1016/S0002-9149(03)00544-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：218 / 221
页数：4
相关论文
共 50 条
  • [1] Commentary on the carvedilol or Metoprolol European Trial (COMET)
    Poole-Wilson, PA
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (9A): : 40B - 42B
  • [2] Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
    Torp-Pedersen, Christian
    Metra, Marco
    Charlesworth, Andrew
    Spark, Phillip
    Lukas, Mary Ann
    Poole-Wilson, Philip A.
    Swedberg, Karl
    Cleland, John G. F.
    Di Lenarda, Andrea
    Remme, Willem J.
    Scherhag, Armin
    HEART, 2007, 93 (08) : 968 - 973
  • [3] Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the Carvedilol or Metoprolol European Trial (COMET)
    Metra, M
    Cleland, JG
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lutiger, B
    Poole-Wilson, PA
    Remme, WJ
    Scherhag, A
    Charlesworth, A
    Swedberg, K
    Torp-Pedersen, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 157A - 157A
  • [4] Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
    Poole-Wilson, PA
    Swedberg, K
    Cleland, JGF
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lubsen, J
    Lutiger, E
    Metra, M
    Remme, WJ
    Torp-Pedersen, C
    Scherhag, A
    Skene, A
    LANCET, 2003, 362 (9377): : 7 - 13
  • [5] Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (01) : 205 - 208
  • [6] Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET
    Poole-Wilson, PA
    Cleland, JGF
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Metra, M
    Remme, WJ
    Swedberg, K
    Torp-Pedersen, C
    EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 321 - 329
  • [7] Metoprolol vs carvedilol in heart failure
    Michael Norton
    Current Controlled Trials in Cardiovascular Medicine, 2000, 2 (1):
  • [8] The substitution of carvedilol for metoprolol in the treatment of systolic heart failure: An economic analysis of the COMET Trial.
    Cykert, S
    Greene, S
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 226 - 226
  • [9] A comparison of adverse events occurring with carvedilol or metoprolol in the treatment of heart failure: Results from COMET
    Poole-Wilson, PA
    Swedberg, K
    Cleland, JG
    Di Lenarda, A
    Hanrath, P
    Lutiger, B
    Komajda, M
    Metra, M
    Remme, WJ
    Scherhag, A
    Charlesworth, A
    Torp-Pedersen, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 205A - 205A
  • [10] Carvedilol protects better against vascular events than metoprolol in heart failure - Results from COMET
    Remme, Willem J.
    Torp-Pedersen, Christian
    Cleland, John G. F.
    Poole-Wilson, Philip A.
    Metra, Marco
    Komajda, Michel
    Swedberg, Karl
    Di Lenarda, Andrea
    Spark, Phillip
    Scherhag, Armin
    Moullet, Christine
    Lukas, Mary Ann
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 963 - 971
12345